At the 8th Annual Microbiome Movement Drug Development Europe in Barcelona, Spain, MicrobiomePost conducted an exclusive interview with Johan van Hylckama Vlieg, CSO and Co-founder of Freya Biosciences, to discuss the latest advancements in microbial immunotherapies for women’s health.
Freya Biosciences: pioneering the development of microbial immunotherapies for women’s health
Johan van Hylckama Vlieg, CSO and Co-founder of Freya Biosciences, discusses the latest advancements in microbial immunotherapies for women's health.
Most recent
Scientific research
22 July 2024
HCPs Area
Industry
- Read more about immunotherapy
Scientific research
22 July 2024
Industry
18 July 2024
Gastroenterology
15 July 2024
